# The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-superior-efficacy-of-anti-pd-1-pd-l1-immunotherapy-in-kras-mutant-non-small/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Chengming Liu,Sufei Zheng,Runsen Jin,Xin‐Feng Wang,Rui Wang,Ruochuan Zang,Haiyan Xu,Zhiliang Lu,Jianbing Huang,Yuanyuan Lei,Shuangshuang Mao,Yalong Wang,Yalong Wang,Xiaoli Feng,Nan Sun,Yan Wang,Yan Wang,Jie He |
| Citations | 285 |
| DOI | 10.1016/j.canlet.2019.10.027 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.sciencedirect.com/science/article/pii/S0304383519305245/pdf |
| OpenAlex ID | https://openalex.org/W2981114563 |
| PMID | 31644929 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Yan Wang](https://scholariq.org/researchers/yan-wang/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.